Please login to the form below
bribery
This page shows the latest bribery news and features for those working in and with pharma, biotech and healthcare.
US piles pressure on Mallinckrodt over alleged Acthar fraud
$700m as a result of “eye-popping price increase” as well as “monopoly, bribery, racketeering, fraud and other deceptive and unfair practices”.
Latest news
-
Sandoz admits antitrust crime, pays $195m in penalties
Cohen, data manipulation involving its gene therapy Zolgensma and bribery and mis-marketing allegations in several countries including the US.
-
Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'
This conduct consists of a complex, multipart scheme involving monopoly, bribery, racketeering, fraud and other deceptive and unfair practices.”. ... Finally, Humana alleges Mallinckrodt maintained the artificially inflated demand “through a
-
Novartis raises 2019 guidance as new products gather speed
Narasimhan also confirmed that the company was setting aside a sizeable sum of $700m in the hope of settling a bribery lawsuit in the US.
-
Novartis close to US bribery settlement
Company faces huge damages pay out
-
Global ban on pharma freebies, including cultural gifts
However these and all other gifts have been outlawed, with the aim of eliminating suspicions of bribery or inappropriate influence. ... China's authorities have cracked down on bribery among state employees and healthcare professionals, and fined GSK
More from news
Approximately 15 fully matching, plus 59 partially matching documents found.
Latest Intelligence
-
Biopharma's Future: Made in China
One of the most serious concerns is bribery, corruption and fraud, well-known problems in the country in recent times. ... So how does AZ ensure it doesn’t get entangled in bribery or corruption in China?
-
Risky business for pharma
to consider, including but not limited to bribery and corruption, money laundering, competition and antitrust, cybersecurity, data privacy and regulation and compliance. ... posing the most significant risks overall”, perhaps due to continued
-
Stress testing for the perfect compliance storm
Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery. ... However, EY’s Global Fraud Survey 2016 shows 11% of company
-
Harnessing commercial innovation
However, the situation in China was about to change significantly. Christian took up his China Region post in August 2013, when the full ramifications of the bribery scandal at GlaxoSmithKline had
-
The Heart of the Matter 5 - the only way is ethics
The strengthening of international regulations around anti-bribery – and renewed vigour in their enforcement – has placed pharmaceutical companies under unparalleled scrutiny.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Astellas appoints ethics and compliance and US legal leaders
Wanda (pictured) now takes on the role of executive director, anti-bribery and anti-corruption in the Japanese firm's ethics and compliance organisation, reporting to Catherine Wertjec, SVP ethics and
-
Former RBS head takes the reins as GSK chair
The UK's biggest drugmaker will certainly be hoping this level of experience can be applied by Sir Philip towards rebuilding GSK's reputation in China following the bribery scandal of
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
-
B2B media account director
-
Competitive salary
- AM / Senior Account Manager – Healthcare PR - London / Remote
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- FREELANCE Associate Director - Healthcare PR - Remote or London
-
Superb Day Rate &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- MHRA approves second COVID-19 antibody treatment
- Roche acquires test maker TIB Molbiol
- Sanofi to buy acne specialist Origimm
- Merck enters agreement with Hanmi for investigational NASH drug
- AstraZeneca blocks take-private buyout of Sobi
- Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer
No results were found
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- Diversity in clinical trials: looking back at our 2021 blogs
- In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
